Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.35 USD | -5.43% | +1.64% | -66.22% |
Apr. 18 | Sector Update: Health Care Stocks Ease in Afternoon Trading | MT |
Apr. 18 | Moleculin Biotech Secures Orphan Drug Label For Annamycin in EU | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 9.69M |
---|---|---|---|---|---|
Net income 2024 * | -30M | Net income 2025 * | -33M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.38
x | P/E ratio 2025 * |
-0.54
x | Employees | 18 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.35% |
Latest transcript on Moleculin Biotech, Inc.
1 day | -5.43% | ||
1 week | +1.64% | ||
Current month | -26.40% | ||
1 month | -23.75% | ||
3 months | -42.82% | ||
6 months | -40.84% | ||
Current year | -66.22% |
Managers | Title | Age | Since |
---|---|---|---|
Donald Picker
FOU | Founder | 78 | 15-07-27 |
Walter Klemp
CEO | Chief Executive Officer | 64 | 15-07-27 |
Jonathan Foster
DFI | Director of Finance/CFO | 60 | 16-08-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Walter Klemp
CEO | Chief Executive Officer | 64 | 15-07-27 |
Michael Cannon
BRD | Director/Board Member | 78 | 15-06-30 |
John Climaco
BRD | Director/Board Member | 55 | 17-07-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 4.35 | -5.43% | 7,365 |
24-04-23 | 4.6 | +6.98% | 7,430 |
24-04-22 | 4.3 | -7.53% | 16,771 |
24-04-19 | 4.65 | +2.80% | 10,562 |
24-04-18 | 4.524 | +5.69% | 49,640 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-66.22% | 10.25M | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- MBRX Stock